AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Snipd AI
The podcast explores the business story behind blockbuster drugs like Ozempic for weight loss. It focuses on the Novo Nordisk scientist who invented the compound paving the way for Ozempic. It discusses the development, impact, and challenges faced in the pharmaceutical market and the affordability issues related to weight loss medications.
Read more
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Development of GLP-1 drugs for weight loss originated from Novo Nordisk's innovation.
- Affordability of GLP-1 medications poses a significant barrier for individuals seeking weight loss treatment.
Deep dives
Development of GLP-1 Drugs for Weight Loss
The podcast episode delves into the origin story of GLP-1 drugs, specifically focusing on Novo Nordisk's development of Ozempic. Initially designed to treat diabetes, these drugs were found to aid in weight loss. The journey of creating a long-lasting GLP-1 compound that led to the development of liraglutide, later known as Victoza, is highlighted. Despite initial setbacks, the perseverance and innovation of the team led to the approval of these drugs, paving the way for significant weight loss outcomes.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode